Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced ...
The Scientist

Molecular Diagnostics Provide Powerful Insights Into Disease

The Southern blot, which detects specific DNA sequences, was one of the first molecular diagnostic methods to be widely adopted. 2 This type of probe-based assay uses a single-stranded oligonucleotide ...
Nature

Molecular mechanisms and biotechnology applications of CRISPR–Cas12a

CRISPR–Cas12a is a versatile RNA-guided nuclease that has rapidly gained prominence for its dual functionality in genome editing and nucleic acid detection. In this Review, we discuss the structural, ...

iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant

Grant Supports Health Economic Research Comparing In-House versus Send-Out dd-cfDNA Testing in Kidney Transplantation-NASHVILLE, Tenn., June ...
Nature

Clinical utility of targeted RNA sequencing in cancer molecular diagnostics

Precision molecular diagnostics aim to identify alterations providing diagnostic, prognostic and/or therapeutic information, with the goal of tailoring treatment to the specific molecular makeup of ...

ABL Diagnostics Advances Platform-Agnostic NGS Strategy Through DeepChek® Verification on Element Biosciences’ AVITI™

Ongoing verification study supports compatibility of DeepChek® with the AVITI™ platform. Expands opportunities in ...
ET HealthWorld

MOLECULAR DIAGNOSTICS

ETHealthworld.com brings latest molecular diagnostics news, views and updates from all top sources for the Indian Health industry.
Labroots

Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2025

Labroots is excited to announce our 13th Annual Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2025 held on May 14th, 2025! The Precision Medicine: Genomics, ...

Insight Molecular Diagnostics Inc.: IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation

American Journal of Transplantation publishes public pre-proof showing novel CM-score superior to either fractional or absolute measurement of dd-cfDNA aloneGraftAssure assay doubles reliability of po ...

Transplant Diagnostics Market worth $8.14 billion by 2031 | MarketsandMarkets

According to MarketsandMarkets, the Transplant Diagnostics Market is projected to grow from about USD 5.61 billion in 2026 to USD 8.14 billion ...
Labroots

Precision Medicine: Genomics, Proteomics & Molecular Diagnostics Virtual Event Series 2026

Labroots is excited to announce our 14th Annual Precision Medicine: Genomics, Proteomics & Molecular Diagnostics Virtual Event Series 2026 held on May 13th, 2026! The Precision Medicine: Genomics, ...